Skip to main content

Advertisement

Table 3 Clinical characteristics and outcomes in intervention group and control group patients after 3 months

From: Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

  Intervention group Control group T-value Sig.
Mean (S.D.) Mean (S.D.)
General overuse 12.17 (2.19) 12.69 (2.62) 1.583 0.115
General harm 10.61 (2.37) 10.77 (2.93) 0.467 0.641
Beneficial effect of pharmaceuticals 14.91 (1.99) 15.11 (2.15) 0.708 0.480
Beliefs about medicines 36.84 (3.77) 38.43 (4.46) 2.855 0.005a
Sensitive 15.40 (2.61) 15.47 (3.11) 0.165 0.869
Necessity beliefs 18.73 (3.78) 18.46 (4.19) 0.509 0.611
Concern beliefs 12.42 (3.18) 13.25 (4.00) 1.694 0.092
Treatment Satisfaction Questionnaire for Medication (TSQM) 86.68 (11.08) 82.82 (13.40) 2.326 0.021a
Estimated weights for EQ-5D 0.66 (0.39) 0.65 (0.38) 0.076 0.939
Montgomery–Åsberg Depression Scale 21.07 (12.21) 21.01 (12.63) 0.036 0.971
Medication Adherence Scale 5.79 (1.89) 5.04 (1.98) 2.880 0.004a
  1. aSignificantly different